Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical (Oncology: GU)

Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer

Ashwin Singh Parihar, Lisa R. Schmidt, Farrokh Dehdashti and Richard L. Wahl
Journal of Nuclear Medicine May 2022, 63 (5) 713-719; DOI: https://doi.org/10.2967/jnumed.121.262647
Ashwin Singh Parihar
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa R. Schmidt
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farrokh Dehdashti
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri; and
2Siteman Cancer Center, Washington University School of Medicine, Saint Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Wahl
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri; and
2Siteman Cancer Center, Washington University School of Medicine, Saint Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 63 no. 5 713-719
DOI 
https://doi.org/10.2967/jnumed.121.262647
PubMed 
34413144

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 3, 2021
  • Revision received August 5, 2021
  • Published online April 28, 2022.

Article Versions

  • previous version (August 19, 2021 - 09:49).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Ashwin Singh Parihar1,
  2. Lisa R. Schmidt1,
  3. Farrokh Dehdashti1,2 and
  4. Richard L. Wahl1,2
  1. 1Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri; and
  2. 2Siteman Cancer Center, Washington University School of Medicine, Saint Louis, Missouri
  1. For correspondence or reprints, contact Richard L. Wahl (rwahl{at}wustl.edu).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 4 Citations
  • 2 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
    Caroline Stokke, Jakob Nordberg Nørgaard, Hilde Feiring Phillips, Alexander Sherwani, Syed Nuruddin, James Connelly, Fredrik Schjesvold, Mona-Elisabeth Revheim
    Molecular Imaging and Biology 2022 24 5
  • New Targets for PET Imaging of Myeloma
    Mona-Elisabeth Revheim, Caroline Stokke, Jakob Nordberg Nørgaard, Hilde Feiring Phillips, Alexander Gul Sherwani, Fredrik Schjesvold, James P. Connelly
    Hemato 2021 2 4

Article usage

Article usage: August 2021 to April 2025

AbstractFullPdf
Aug 20211795036
Sep 2021505015
Oct 2021741011
Nov 202118303
Dec 202127906
Jan 202222107
Feb 2022166017
Mar 2022115088
Apr 20222276556
May 202251640096
Jun 202224719740
Jul 2022474613
Aug 2022271310
Sep 2022468535
Oct 20222931727
Nov 20224710824
Dec 20222738018
Jan 20234140132
Feb 20232335722
Mar 20232938649
Apr 20231727535
May 20231322731
Jun 20231318334
Jul 20231022757
Aug 20232634140
Sep 20231028128
Oct 20231111722
Nov 20232913622
Dec 202347427
Jan 20242621220
Feb 2024916919
Mar 2024911428
Apr 2024304716
May 2024124323
Jun 2024255427
Jul 20246410923
Aug 20246310734
Sep 2024144623
Oct 2024132816
Nov 202483427
Dec 202443325
Jan 2025113721
Feb 2025136814
Mar 202595620
Apr 2025138061
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (5)
Journal of Nuclear Medicine
Vol. 63, Issue 5
May 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
Ashwin Singh Parihar, Lisa R. Schmidt, Farrokh Dehdashti, Richard L. Wahl
Journal of Nuclear Medicine May 2022, 63 (5) 713-719; DOI: 10.2967/jnumed.121.262647

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
Ashwin Singh Parihar, Lisa R. Schmidt, Farrokh Dehdashti, Richard L. Wahl
Journal of Nuclear Medicine May 2022, 63 (5) 713-719; DOI: 10.2967/jnumed.121.262647
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
  • A Comparison of 18F-DCFPyL, 18F-NaF, and 18F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
Show more Clinical (Oncology: GU)

Similar Articles

Keywords

  • 18F-fluciclovine
  • Axumin
  • FACBC
  • second malignancy
  • additional neoplasms
  • prostate cancer
SNMMI

© 2025 SNMMI

Powered by HighWire